Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm
Clinical trial NCT01803477 · COMPLETED
Trial details
- NCT number
- NCT01803477
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2013-10-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.